1305 O'BRIEN DRIVE, MENLO PARK, CA
Material disclosure
Announces the Appointment of Chris Gibson to the Board of Directors
Announces Fourth Quarter and Full Year 2025 Financial Results
Interim Leadership Changes at Pacific Biosciences Announced
Completes Sale of Short-Read Sequencing Assets
Announces Preliminary Fourth Quarter and Full Year 2025 Revenue
Announces Third Quarter 2025 Financial Results
Financial Results, Press Release
FY 2024
Q3
Q2
Q1
Registration Statement for Securities to be Offered to Employees
S-3ASR
Notice of Exempt Offering of Securities
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Specialized Disclosure Report
Automatic Shelf Registration Statement